Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0001923794-26-000004

Chief Technology Officer sold 7,000 shares at $12.00 ($84,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Tyagarajan Seshu · Chief Technology Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-17 Sale : show line 1 in the form 10b5-1 −7,000 $12.00 $84,000 76,865 D
Open-market sales · 7,000 sh · avg $12.00 · $84,000
Loading xslF345X06/ownership.xml…